A UTF1-based selection system for stable homogeneously pluripotent human embryonic stem cell cultures by Tan, Shen Mynn et al.
Published online 12 September 2007 Nucleic Acids Research, 2007, Vol. 35, No. 18 e118
doi:10.1093/nar/gkm704
A UTF1-based selection system for stable
homogeneously pluripotent human embryonic stem
cell cultures
Shen Mynn Tan
1, Siew Tein Wang
2, Hannes Hentze
2 and Peter Dro ¨ge
1,*
1School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551 and
2ES Cell
International Pte Ltd, 11 Biopolis Way, #05-06 Helios, 138667 Singapore
Received March 2, 2007; Revised August 7, 2007; Accepted August 24, 2007
ABSTRACT
Undifferentiated transcription factor 1 (UTF1) was
identified first in mouse embryonic stem cells and is
also expressed in human embryonic and adult stem
cells. UTF1 transcription ceases at the onset of
differentiation, which clearly distinguishes it from
less sensitive pluripotency markers, such as Oct4 or
Nanog. We present here two transgenic hESC lines,
named ZUN. Each line harbors one copy of the UTF1
promoter/enhancer driving a resistance gene and
yielded highly homogeneous cultures under selec-
tion pressure, with a larger proportion of Oct4 and
Sox2 positive cells. While ZUN cultures, like parental
HUES8 cultures, retained the capacity to differenti-
ate into tissues of all three germ layers using a SICD
mouse teratoma model, they surprisingly exhibited
an increased refractoriness to various differentia-
tion cues in vitro. Together with its small size of only
2.4 kb for the entire cassette, these features render
our selection system a powerful novel tool for many
stem cell applications and human somatic cell
reprogramming strategies.
INTRODUCTION
The transcriptional co-activator ‘undiﬀerentiated tran-
scription factor 10 (UTF1) is expressed in both mouse and
human embryonic stem cells (mESCs and hESCs,
respectively) (1–3). UTF1 interacts with ATF-2 and
TBP-containing complexes, and seems to be involved in
cell proliferation control (4,5). UTF1 is regarded as one of
the most important pluripotency marker genes deﬁning
the hESC niche (6,7). Importantly, its transcriptional
regulation is very sensitive to diﬀerentiation cues and
switched oﬀ faster and with a larger magnitude than either
Oct4 or Sox2 during embryoid body formation from both
mouse and human ESCs (8–10). A similar response is seen
when mouse embryonic carcinoma (EC) and mESCs were
triggered to diﬀerentiate by retinoic acid (RA) (11,12).
In a comparison of hESCs cultured in medium containing
either fetal calf serum or deﬁned serum replacement,
UTF1 was found to be downregulated to a larger extent
in serum medium compared to Oct4 or Sox2, suggesting
strongly that it is a very reliable marker for early
diﬀerentiation (13). Furthermore, RNA interference
(RNAi) of Oct4 transcripts in mESCs has been shown to
cause downregulation of UTF1 transcripts (14), and more
than 90% of all cells in undiﬀerentiated mESC popula-
tions stain positively for both these markers (15). These
two experiments further allude to the prevalence of UTF1
and Oct4 co-expression in undiﬀerentiated ESCs.
Human embryonic stem cell cultures are always
heterogeneous and usually contain a subset of less
pluripotent and, hence, more diﬀerentiated cells (16–18).
This is also true for mouse and medaka ESCs (19,20).
It was shown that the presence of minor populations of
diﬀerentiated cells compromises the pluripotency of entire
stem cell cultures (21). These features represent a severe
problem for many hESC applications which can be
addressed either via ﬂuorescence-activated cell sorting
(FACS) in order to isolate pluripotent hESCs or
by antibiotic selection as a means to eliminate diﬀerentiat-
ing cells.
FACS strategies generally utilize transgenes, such as
EGFP, under the control of genetic elements of a
pluripotency marker. For example, mouse Rex1-EGFP
and Oct4-EGFP combinations have been used in hESCs to
screen for undiﬀerentiated cells via ﬂow cytometry
(17,22,23). A recent improvement in semi-automated
FACS and clonal recovery utilized a mouse Oct4-EGFP
construct to sort for pluripotent hESCs (24). However,
this procedure has to be repeated routinely in order to
ensure more homogeneous hESC cultures over longer
periods of time.
Antibiotic selection has the advantage of being less
intrusive to hESCs. Expression of the neomycin resistance
(Neo) gene and G418 antibiotic selection, along with
EGFP expression, have been shown to be compatible with
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combination has been used to isolate ES and EC cell lines
from embryos. (19,21,26). Thus far, only one report
utilized the twin markers of EGFP and Neo driven by an
Oct4 promoter for the maintenance of pluripotency in
hESCs (22). However, the ability to select against partially
diﬀerentiated cells as well as the derivation of more
homogeneous pluripotent hESC cultures was not estab-
lished in these studies.
Here we demonstrate that UTF1 is an exceptionally
sensitive pluripotency marker. We found that M1,a
genetic element comprising a conserved octamer sequence
important for Nanog expression (27), is also present and
functional in the UTF1 30 enhancer, but not in the UTR of
Oct4 or Sox2. As a representative example, we present two
stable ZUN hESC lines in which Neo is under the control
of UTF1 promoter/enhancer. Application of G418 selec-
tion results in ablation of diﬀerentiated hESCs and
homogeneously pluripotent ZUN cultures, containing a
signiﬁcantly larger number of Oct4 and Sox2 positive cells
compared to parental cultures. While ZUN cultures retain
the capacity to diﬀerentiate into progenitors of all three
germ layers in vivo, they surprisingly exhibited an
increased refractoriness to diﬀerentiation cues under
various culture conditions.
MATERIALS AND METHODS
Plasmids
The full-length human UTF1 gene was ampliﬁed from
HeLa genomic DNA using primers UTF1-F (CCGGA
ATTCAGCGCCAGGACCGACCCCTTA) and UTF1-R
(TGCTCTAGAGGGTTCAGCACTTCTCCTGCCTC)
via PCR. The product was cleaved with EcoRI and XbaI,
and ligated into phagemid pTZ-18R. The UTF1 coding
sequence was subsequently replaced with that of EGFP or
Neo in the following way. KpnI and NcoI restriction sites
were introduced between the end of the UTF1 promoter
and before the ATG codon by amplifying the promoter
region of pTZ-UTF1 via PCR with primers UTF1-F
and UTF1-MR (CGGGGTACCCCGGGGCTGGGG
CGCGG). The resulting fragment was cleaved with
EcoRI and NcoI, and ligated to a cleaved pCMV-EGFP
which replaces the CMV promoter. The plasmid was then
digested with EcoRI and BsrGI to produce an (EcoRI)
UTF1promoter-EGFP (BsrGI) sticky-ended fragment.
pTZ-UTF1 was used as a PCR template to amplify a
segment of the UTF1 30 UTR region and inserting a BsrGI
RE site near the end of UTF1 transcription unit using
primers UTF1-MF (AGCTGTACAAGTGAGTCCCGG
CTGCGGC) and UTF1-BR (AGAATACTCAAGCTA
TGCATCCAAC). This produced another BsrGI-BamHI
sticky-ended 1kb fragment. pTZ-UTF1 was then digested
with EcoRI and BamHI, and this 3.2kb fragment
was ligated to the above two 1kb fragments, yielding
pTZ-UTF1-EGFP. The Neo gene was ampliﬁed with
ﬂanking KpnI and BsrGI RE sites via PCR with
pPGK-Neo as template and Neo-F (CTGGGTACCCC
ATGATTGAACAAGATGG) and Neo-R (ACTGTGTA
CATCAGAAGAACTCGTCAAGAA) primers.
The pTZ-UTF1-EGFP backbone was digested with
KpnI and BsrGI to remove EGFP, and ligated with the
cleaved Neo fragment to yield pTZ-UTF1-Neo. The
promoter-less version of pTZ-UTF1-EGFP was generated
using EcoRI and KpnI to remove the UTF1 promoter.
The ends were blunted using Klenow Fragment (NEB)
followed by self-ligation. The enhancer-less version of
pTZ-UTF1-EGFP was generated using PstI to remove the
UTF1 enhancer followed by self-ligation.
pTZ-UTF1-EGFP was used as template to introduce the
mutant M1 sequence (GTAGTGGT; original sequence
GTCTGGGT) (27). Flanking arms 200 bp from M1 were
ampliﬁed using two primer pairs, UTF1-M1F (GACCCA
GGAGTAGCATG) and UTF1-M1mR (CTAGGCCCA
CCACTACCAGAGCCAC) (near the 50 XcmI RE site),
and UTF1-M1mF (GTGGCTCTGGTAGTGGTGGGC
CTAG) and UTF1-M1R (CATTGTTATGCTAGCGG)
(near the 30 NheI RE site). These were combined via
assembly PCR using UTF1-M1F and UTF1-M1R as
primers. The resulting 370 bp fragment was digested
with XcmI and NheI, and ligated to a similarly cleaved
pTZ-UTF1-EGFP in order to replace the original
M1 sequence.
Plasmids were ampliﬁed in Escherichia coli strain
DH5a. We used standard PCR conditions with Pfu poly-
merase (Promega). Restriction enzymes were from New
England Biolabs.
Cell culture, transfection and differentiation
F3 human foreskin ﬁbroblasts (28), A549 and HeLa
carcinoma cell lines were cultured according to standard
procedures. hESC line hES2 (karyotype: 46XX) was
obtained from ES Cell International Pte Ltd. HUES8
(karyotype: 46XY) and HUES9 (karyotype: 46XX, inv9)
was provided by the Harvard Stem Cell Institute. hESCs
were cultured on G418-resistant MEFs (PMEF-N,
Chemicon), as previously described (29,30).
F3, A549 and HeLa cells were transfected with 10mgo f
reporter plasmid via electroporation as described
previously (31). hESCs were transfected with 2mgo f
reporter plasmid and Eﬀectene (Qiagen) as described
previously (29).
Diﬀerentiation medium was prepared by removing
basic ﬁbroblast growth factor and exchanging knockout
serum replacement with fetal bovine serum (all three from
Gibco). Spontaneous diﬀerentiation was conducted on
matrigel (BD Biosciences) or gelatin surfaces without
MEFs. Induced diﬀerentiation on MEFs was conducted
either with 10mM (RA) or 1% (DMSO) (Sigma) which
was added to diﬀerentiation medium (32). Embryoid body
formation was induced by plating hESCs onto low-cell
binding plates (Nunc).
SCID mouse teratoma assay
To test the diﬀerentiation potential of hESC lines in vivo,
serially passaged hESCs were manually harvested and
injected as clumps with an approximate cell dose of
2 4 10
6 cells in a volume of 50 ml into the quadriceps
of the right hind limb of a male SCID mouse (3 mice/hESC
line). Mice were maintained under controlled conditions
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(NIH) and National Advisory Committee for Laboratory
Animal Research (NACLAR) guidelines, and with
approval of the Biopolis Institutional Animal Care and
Use Committee (Biopolis IACUC approval 050008,
National University of Singapore Institutional Review
Board 05-020). Teratoma formation was monitored
visually using a simple grading system that was
conﬁrmed by caliper measurements (grade 0—no detect-
ible enlargement, grade 1—enlargement just detectible,
grade 2—obvious enlargement, grade 3—enlargement
impedes locomotion). When teratomas reached grade 3
(after 6–8 weeks), teratomas weighing 1–2g were excised,
ﬁxed (Bouin’s solution), paraﬃn-embedded, sectioned
and histologically analyzed following staining with
hematoxylin and eosin. Additionally, teratomas were
assessed by a pathologist at the Department of
Pathology, National University of Singapore.
Characterization of ZUN hESC lines
ZUN cell lines were generated by transfecting HUES8
cells using Eﬀectene with pTZ-UTF1-Neo. Individual
colonies were mechanically expanded in the presence of
G418 (500mg/ml). Cloning eﬃciency was 10
 5, with four
stable cell lines generated, of which only two contained
the full-length UTF1-Neo cassette. These two lines were
analyzed here and labeled as ‘ZUN’. Karyotyping via
Giemsa staining was performed by Cytogenetics Lab,
KK Women’s and Children’s Hospital, Singapore. 50mlo f
BrdU/Colcemid (50:50) mixture was added to an 80%
conﬂuent 35mm dish containing hESCs with 2ml of
medium the night before staining and analysis. Transgenic
genomic inserts in both cell lines were sequenced from
correctly sized genomic PCR products ampliﬁed using
standard Taq PCR protocols and UTF1-F and UTF1-R
primers. Southern blotting was performed as previously
described (33), with 10mg of isolated genomic DNA
digested with EcoRI. Neo was detected using a
32P-labeled
Neo probe. WST-1 cell proliferation assays were con-
ducted using manufacturer protocols (Roche). Brieﬂy,
3 10
4 cells were seeded onto each MEF-layered 96-well
at day 0. WST-1 reagent was added to the wells for 30min
the next day, and 440nm readings were recorded using
a standard photoplate reader. This was repeated for a
total of 4 days with diﬀerent plates. Each cell line had
ﬁve replicates per time-point. Alkaline phosphatase
staining and TRA-1-60/TRA-1-81 surface marker immu-
nostaining (visualized with FITC) were conducted using
manufacturer protocols (Chemicon). Flow cytometry of
surface markers, Oct4 and Sox2 was performed as
previously described (29), with pre-incubation of
primary and FITC-conjugated secondary antibodies
(Santa Cruz).
Quantitative real-time PCR
Total RNA was recovered from cell pellets (Qiagen) and
cDNA was synthesized via the SSII reverse transcriptase
kit, primed with oligo dTs (Invitrogen). SYBR Green
qRT-PCR (Qiagen) was conducted using the 7500
real-time PCR System and results analyzed using sequence
detection software (SDS) version 1.2.3 (Applied
Biosystems). All experiments had at least biological
duplicates and assay triplicates, and results were analyzed
via the Ct method using GAPDH as the housekeeping
transcript. Primers used were as follows: GAPDH
(CCCACTCCTCCACCTTTGAC and CTCCCCTCTT
CAAGGGGTCT), Nanog (AGTCCCAAAGGCAAAC
AACCCACTTC and ATCTGCTGGAGGCTGAGGTA
TTTCTGTCTC) (6), Oct4 (CTTGCTGCAGAAGTGGG
TGGAGGAA and CTGCAGTGTGGGTTTCGGGCA)
(1), Sox2 (ATGCACCGCTACGACGTGA and CTTTT
GCACCCCTCCCATTT) (1), UTF1 (AGCAGATCCGG
AAGCTCATGGG and TCCTCGGGGATGCAGGTG),
UTF1-Neo (GGGTACCCCATGATTGAACA and CA
GGTCGGTCTTGACAAAAAG), Sox9 (GAAGCTCGC
GGACCAGTA and CGTTCTTCACCACTTCCTC),
Nestin (CGTTGGAACAGAGGTTGGAG and GAGC
GATCTGGCTCTGTAGG), ID2 (CTGGACTCGCA
TCCCACTAT and CACACAGTGCTTTGCTGTCA),
HAND1 (TGCCTGAGAAAGAGAACCAG and
ATGGCAGGATGAACAAACAC) (9), IGF2 (TCCTC
CCTGGACAATCAGAC and AGAAGCACCAGCAT
CGACTT) (9), a1AT (AGACCCTTTGAAGTCAAG
GACACCG and CCATTGCTGAAGACCTTAGTG
ATGC) (34).
RESULTS
UTF1is asensitive pluripotency marker for hESCs
We evaluated ﬁrst the sensitivity of UTF1 expression with
respect to induced diﬀerentiation using quantitative real-
time PCR (qRT-PCR). Various hESC lines were triggered
to diﬀerentiate via retinoic acid (RA) or dimethyl
sulfoxide (DMSO) treatment. The results show that this
almost completely abolished UTF1 expression; a response
that was not observed for Nanog and Oct4 (Figure 1A).
We next generated the following three UTF1 transgenic
constructs: pTZ-UTF1, pTZ-UTF1-EGFP and pTZ-
UTF1-Neo (Figure 1B). In addition, three variants of
pTZ-UTF1-EGFP were designed: one without the minimal
50 promoter, one lacking the 30 enhancer, and one
containing an altered M1 sequence. The M1 octamer
sequence was found to be conserved in the Nanog
promoter of many species (27), and we identiﬁed it
recently upstream of the Oct4/Sox2 binding site within
the 30 UTF1 enhancer.
The results demonstrate hESC-speciﬁc expression of the
full-length pTZ-UTF1-EGFP after transfection into var-
ious human cell lines and hESC line HUES8 (Figure 1C).
We next introduced the three pTZ-UTF1-EGFP versions
into HUES8 cells and showed that the 50 promoter and
30 enhancer regions were essential for EGFP expression
(Figure 1C). In addition, the altered M1 element
reproducibly led to a signiﬁcantly smaller number of
EGFP expressing hESCs, which is similar in magnitude to
its reported eﬀect on Nanog transcription (27). Together,
these data conﬁrm that UTF1 transcription is a very
sensitive pluripotency marker speciﬁc for hESCs and
suggests that its regulation in hESCs involves M1-binding
factors in addition to Oct4 and Sox2.
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We established stable pTZ-UTF1-Neo cell lines from
HUES8 cells via random genomic transgene insertion.
Two single-copy lines with normal karyotype, dubbed
ZUN1 and ZUN2, were used in subsequent experiments
(Supplementary Figure S1). Careful characterization of
both lines revealed that they have similar proliferation
rates (Supplementary Figure S2), exhibit comparable
alkaline phosphatase (AP) staining patterns
(Supplementary Figure S3), and express Nanog at a
similar level as parental HUES8 cells (Figure 2A).
However, an elevated level of Oct4, Sox2 and UTF1 in
ZUN cultures was reproducibly detected by qRT-PCR
(Figure 2B). This correlation of expression supports the
notion that the control of UTF1 involves factors Oct4 and
Sox2, but most likely not Nanog (35).
Figure 1. UTF1 expression in hESCs. (A) qRT-PCR Expression
analysis of RA- (for 12 days) and DMSO-induced (for 7 days)
diﬀerentiation in hESCs, normalized to that of respective undiﬀer-
entiated hESC lines, with two biological replicates for each sample.
(B) Schematic drawing of vectors. Full-length UTF1 was cloned into
phagemid pTZ-18R yielding pTZ-UTF1. Its coding region was
subsequently replaced with enhanced green ﬂorescent protein (EGFP)
or neomycin (Neo), yielding pTZ-UTF1-EGFP and pTZ-UTF1-Neo,
respectively. Red text indicates alterations in pTZ-UTF1-EGFP.
(C) Flow cytometry of UTF1-driven EGFP expression in various cell
lines following transient transfection of pTZ-UTF1-EGFP. Transfection
eﬃciencies were normalized to those determined in parallel using
pCMV-EGFP and are the average of three biological replicates.
See Supplementary Figure S7 for representative dot plots.
Figure 2. Characterization of ZUN hESC lines. (A) Expression analysis
of ZUN hESCs. qRT-PCR comparison of pluripotency markers across
the three hESC cultures normalized to HUES8 samples, performed
with biological triplicates. (B) Oct4 and Sox2 expression analysis of
ZUN hESCs. Percentage of hESCs expressing Oct4 and Sox2. ZUN
cultures consist of signiﬁcantly more Oct4- and Sox2-expressing cells
compared to HUES8, based on the two-tailed paired Student’s t-test
(P-values<0.05). (C) Surface marker analysis of ZUN hESCs.
Percentage of positively stained hESCs for TRA-1-60 and TRA-1-81.
Both ZUN lines consist of signiﬁcantly more positively stained cells
compared to parental HUES8, based on the two-tailed paired Student’s
t-test (P-values<0.05). (D) qRT-PCR analysis of removal and
restoration of G418 selection pressure on ZUN1 and ZUN2 cultures.
ZUN lines were cultured in the presence of G418 for 90 days (+G418);
G418 removed for 30 ( G418) or 60 ( / G418) days; G418 removed
for 30 days and re-introduced for 30 days ( /+G418). Expression
levels were normalized to +G418 values and presented as an average of
three experimental repeats.
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of global Oct4, Sox2 and UTF1 expression was due to
the presence of a larger fraction of cells that express these
markers. A statistically signiﬁcant higher percentage of
ZUN cells stained positive for Oct4 and Sox2 compared
to HUES8 cultures (Figure 2B). We could also demon-
strate that ZUN cultures contained more cells
which stain positive for surface markers TRA-1-60 and
TRA-1-81 (Figure 2C). These results indicate that HUES8
cultures contained more hESCs with a low expression level
of pluripotency markers. In contrast, such cells have been
ablated in ZUN cultures via G418 selection.
We next analyzed the eﬀect of sequential removal
and restoration of G418 selection on both ZUN lines
and employed qRT-PCR of pluripotency markers
Nanog, Oct4, Sox2 and UTF1 for the detection of
the onset of diﬀerentiation (9). We also included the
transgene UTF1-Neo in this analysis because its regulation
should be linked to that of the endogenous UTF1. The
results show that spontaneous diﬀerentiation can be
detected in cultures during 60 days of G418 withdrawal.
This is indicated by the progressive reduction in
signals obtained from all markers, with the exception of
Sox2 (Figure 2D). However, upon re-application of
antibiotic selection, original expression levels could be
restored in these cultures. Using a transgenic hESC line in
which Neo is expressed from the elongation factor 1
alpha (EF-1 ) promoter as a control, we conﬁrmed that
G418 withdrawal has no eﬀect on the expression of
this set of markers which clearly links this eﬀect to
the presence of the UTF1-Neo transgene in hESCs
(Supplementary Figure S4). Together, these data show
that ZUN cultures are more homogeneously pluripotent
than the parental cultures and that G418 addition and
subsequent ablation of diﬀerentiated ZUN cells is
required to sustain homogeneous cultures over longer
periods of time.
ZUN cultures are refractory tovarious differentiation cues
We demonstrated above that ZUN cultures are more
homogeneously pluripotent than the parental cultures.
We were interested, therefore, in investigating the
diﬀerentiation behavior of ZUN cells. First, we induced
diﬀerentiation by plating them on matrigel or gelatin
without supporting mouse embryonic ﬁbroblasts (MEFs)
and in the absence of G418. In the matrigel protocol,
HUES8 cells quickly initiated diﬀerentiation as indicated
by the 5-fold downregulation of our panel of markers
(Figure 3A). However, both ZUN lines maintained
signiﬁcantly higher overall expression levels even after
12 days of culture. Similarly, the gelatin protocol induced
a 2-fold downregulation of Oct4 and UTF1 in HUES8,
but not in ZUN populations. We observed further that
under these conditions, ZUN cultures have a larger
number of colonies consisting of cells which display a
more compact morphology that stain stronger for alkaline
phosphatase (AP), and a reduced occurrence of diﬀer-
entiating cells at colony edges. Upon subsequent addition
of G418 for 2 days, only pluripotent cells that stained for
AP survived in ZUN cultures, demonstrating again that
diﬀerentiating ZUN cells are rapidly and eﬃciently
ablated by G418 selection (Figure 3B).
We analyzed next the eﬀects of RA or DMSO treatment
on ZUN cultures in the absence of G418 selection.
After 12 and 7 days, respectively, qRT-PCR showed that
ZUN cultures exhibited a lower rate of diﬀerentiation in
comparison to HUES8 cultures (Figure 4A). Notably,
UTF1 and UTF1-Neo expression diminished by the largest
magnitude among the pluripotency markers. Certain
diﬀerentiation markers also indicated a slower onset of
diﬀerentiation in ZUN cultures. HUES8 cultures showed
a greater (2- to 10-fold) upregulation of Sox9, Nestin
and ID2 due to RA treatment, and of HAND1, IGF2
and Nestin after exposure to DMSO (Figure 4B).
The expression of surface markers of pluripotency,
Figure 3. Diﬀerentiation of ZUN hESC lines on Matrigel and Gelatin. (A) Expression analysis of spontaneous diﬀerentiation using pluripotency
markers. The qRT-PCR of hESCs without MEFs plated on gelatin or matrigel for 12 days was performed with biological triplicates, and presented
as expression levels relative to that of respective undiﬀerentiated cell lines. (B) AP staining of hESCs on gelatin and matrigel. Representative phase
contrast photomicrographs comparing HUES8 and ZUN cell morphologies on the 12th day and visualization of the ablative eﬀects after 2 days of
exposure to G418. Scale bar: 55mm.
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analyses, showing that HUES8 cells exhibited a more
muted staining pattern compared to ZUN colonies
(Figure 4C). These results conﬁrm our conclusion that
under various conditions, ZUN cultures exhibit a more
robust phenotype against the onset of diﬀerentiation than
parental cultures.
ZUNcellsretainthecapacitytodifferentiateintoprogenitors
ofall three germ layersin vitro andin vivo
The observed phenotype of increased robustness against
the onset of diﬀerentiation led us to investigate ZUN
cultures under long term diﬀerentiation conditions. The
results show that ZUN and HUES8 cells cultured under
RA and DMSO diﬀerentiation protocols for 30 days show
similar morphologies and lack of AP staining
(Supplementary Figure S5). These cells were completely
ablated upon addition of G418, as were those in equally
long-term gelatin and matrigel cultures (data not shown).
In addition, 21 days of embryoid body formation in
suspension cultures caused a signiﬁcant upregulation of
diﬀerentiation markers from all three germ layers
(Figure 4D). Both ZUN lines and HUES8 show very
high expression of HAND1, IGF2 and ID2 as indicated by
the large fold increase relative to their undiﬀerentiated
counterparts. They also show relatively high expression of
a1 anti-trypsin ( 1AT) and Sox9. The morphological
characteristics and growth rates of HUES8 and ZUN cell-
derived EBs were indistinguishable (Supplementary
Figure S6). Furthermore, we showed by a teratoma
assay that the parental HUES8line as well as ZUN1 and
Figure 4. Diﬀerentiation of ZUN hESCs induced by RA and DMSO. (A) Expression analysis of induced diﬀerentiation using pluripotency markers.
qRT-PCR of hESCs on MEFs induced to diﬀerentiate via RA (for 12 days) or DMSO (for 7 days) in diﬀerentiation medium. (B) Transcript analysis
of induced diﬀerentiation using diﬀerentiation markers. (C) TRA-1-60 and TRA-1-81 surface marker immunostaining for induced diﬀerentiation,
comparing HUES8 with ZUN cultures. The bottom row shows a control panel of undiﬀerentiated HUES8 cells stained with secondary antibody
only, TRA-1-60 or TRA-1-81 antibodies (left to right). Scale bar: 30 mm. (D) Transcript analysis after EB formation. qRT-PCR of EBs from hESCs
induced to diﬀerentiate for 21 days in suspension cultures. The qRT-PCR experiments were performed with biological duplicates, and presented as
expression levels relative to that of respective undiﬀerentiated cell lines.
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ectodermal structures, mesoderm such as cartilage and
bone, as well as mesodermal glandular structures) when
transplanted into immune-deﬁcient SCID mice (Figure 5).
We conclude, therefore, that the robustness which our
ZUN cultures displayed against the onset of diﬀerentia-
tion induced by various protocols does not compromise
their potential to diﬀerentiate, like parental cultures, into
all three germ layers in vitro and in vivo.
DISCUSSION
Expression of UTF1 is controlled by a 50 TATA-less
promoter consisting of four GC boxes. The 30 enhancer
element harbors a twin octamer sequence where the
synergistic binding of Oct4 and Sox2 is essential for
UTF1 expression in both mouse and human ESCs
(8,35). Sp1-like transcription factors that bind to
GC boxes present in the UTF1 promoter are most likely
involved in the regulation of UTF1, since they are
regarded as regulators of embryonic development in
vertebrates (36) and shown to be involved in the
transcriptional control of both Oct4 and Nanog (37,38).
We showed here that UTF1 is indeed expressed in hESCs,
but not in human primary ﬁbroblasts and carcinoma cell
lines. Further, both 50 promoter and 30 enhancer are
needed for expression. A novel ﬁnding is that an octamer
sequence (M1) which is conserved in the Nanog promoter
of many species (27) is also present upstream of the
analogous human Oct4/Sox2 cognate sequence in the 30
UTF1 enhancer. The fact that M1 mutations resulted in
equally muted expression levels of UTF1 and Nanog,
strongly suggests that similar M1-binding factor(s) are
involved in the control of both pluripotency marker genes.
Our results also conﬁrm previous reports showing that
endogenous UTF1 is downregulated faster than Oct4 or
Nanog at the onset of diﬀerentiation to nearly undetect-
able levels. In addition, detailed analysis of SymAtlas data
from the Genomics Institute of the Novartis Research
Foundation showed that both UTF1 and Nanog expres-
sion are greatly diminished at day 8.5 of mouse embryo
formation, unlike Oct4 or Sox2 (http://symatlas.gnf.org).
Together, these results ﬁrmly establish UTF1 as a sensitive
and reliable pluripotency marker for hESCs.
Recent reports revealed that UTF1 is also an important
marker expressed in other stem cell types. For example,
spermatogonial stem cells isolated from adult mouse testis
were shown to exhibit features reminiscent of pluripotent
ESCs. These cells express Oct4, Nanog, Rex1 and UTF1
and, interestingly, also downregulate UTF1 signiﬁcantly
faster than these other markers upon embryoid body
formation (39). Further, pluripotent stem cells derived
from re-programmed primary mouse ﬁbroblasts through
co-expression of transgenes encoding Oct4, Sox2, c-Myc
and Klf4 also express UTF1. It is noteworthy that the
expression level of UTF1 in pluripotent stem cells derived
from diﬀerent sources is always more tightly linked with
Figure 5. Teratoma formation SCID mice studies. The hESC lines ZUN1 (A), ZUN2 (B) and the parental line HUES8 (C) were injected into the
hind leg of male SCID mice, and the teratoma formation was followed by a simple grading system (see Materials and Methods section). When
teratomas were full developed (1–2g tissue weight, 6–8 weeks), they were harvested and processed by routine histological procedures, followed by
heamatoxilin/eosin staining. (D) Detailed histology of ectodermal (epithelium, neuroectoderm), mesodermal (bone in red, cartilage in blue) and
endodermal (glandular structures) structures are shown for each hESC line.
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like Cripto or Nanog (40). These data, in conjunction with
results presented here, indicate that our UTF1-based
selectivity tool should be widely applicable to select for
pluripotent human stem cell lines derived from diﬀerent
sources.
We demonstrated that the control of both endogenous
and exogenous UTF1 in ZUN cells is linked, as expected,
and that UTF1-driven Neo expression in hESCs in
conjunction with G418 selection can be used to eﬃciently
ablate diﬀerentiating cells in standard culture conditions.
This resulted in ZUN cultures which display a higher
global expression level of key pluripotency markers.
We showed that this elevated level is most likely due to
an increase in the fraction of Oct4 and Sox2 positive
hESCs. Furthermore, the number of cells staining positive
for surface markers TRA-1-60 and TRA-1-81 was also
elevated which, if taken together, indicates that ZUN
cultures are more homogeneously pluripotent than the
parental cultures (Figure 2A–C). Upon removal of
selection pressure from ZUN cultures, the overall expres-
sion level of these markers declined, which indicates loss
of pluripotency and, consequently, more heterogeneous
hESC cultures. Interestingly, the absence of selection
pressure for 60 days did not cause widespread silencing of
the exogenous UTF1-Neo. This enabled us to add G418
only periodically in order to select against diﬀerentiating
hESCs in ZUN cultures. Hence, the UTF1 promoter/
enhancer combination could be a generally applicable
control element for sustained expression of transgenes in
pluripotent hESCs, even in the absence of selection.
We showed that the generation of ZUN lines harnessed
the sensitivity of UTF1 as a pluripotency marker which
resulted in rapid and eﬃcient ablation of diﬀerentiating
cells. An unexpected ﬁnding was the refractoriness of
ZUN cultures to the onset of diﬀerentiation. We attribute
this phenotype to the increased fraction of pluripotent
hESCs in homogeneous ZUN cultures compared to
typical, more heterogeneous hESC cultures. Given the
propensity for heterogeneous cultures to spontaneously
diﬀerentiate (21), the increased stability of human stem
cell cultures with respect to the uniformity in pluripotency
combined with eﬃcient ablation of diﬀerentiating cells
oﬀered by the ZUN system could signiﬁcantly improve
large scale growth for many future hESCs applications.
In addition, ZUN cultures show a higher expression
of pluripotency markers when compared to HUES8
cultures following thawing after standard slow cooling
cryopreservation procedures (data not shown), thereby
counteracting a reported negative eﬀect associated with
cryopreservation (41).
An intrinsic advantage of the UTF1-based selection
system over other pluripotency marker-based strategies is
its enhanced sensitivity towards many diﬀerentiation
pathways. Although the well-characterized pluripotency
marker Oct4 has been a component in strategies for both
mouse and human ESCs (21,22), the use of Oct4 in this
context can be problematic. Apart from being less
sensitive to the onset of diﬀerentiation, its expression
level is also very tightly controlled. A less than 2-fold
increase in Oct4 expression alone leads to diﬀerentiation
into primitive endodermal and mesodermal lineages in
mouse ESCs (42). This implies that the Oct4-Neo system is
potentially less sensitive to these diﬀerentiation pathways,
and, thus, will not be able to eﬃciently ablate cells that are
undergoing diﬀerentiation into these lineages. In addition,
the <2 kb length of the entire human UTF1 promoter/
enhancer element represents a signiﬁcant advantage for
genetic manipulation of hESCs, or other human cell types,
if one compares this to an unwieldy 8 kb of the Oct4
control element.
Our ZUN system has a large range of potential
applications. In its current context as a stable transgene
in hESCs, it can be used for the maintenance of
homogeneously pluripotent cultures. In combination
with gene targeting technologies, this application can be
upscaled to meet the larger cell quantities ultimately
needed for stem cell-based therapies. ZUN lines can also
be employed to screen and characterize synthetic factors,
media components or surface matrices that permit
maintenance of pluripotency, and it can be used to test
3D scaﬀolds or aid in the derivation of new hESC lines.
As indicated above, the ZUN system shows potential
in selection protocols in order to isolate adult stem cells
from primary cultures. It can also be used in hESCs in
conjunction with cell diﬀerentiation strategies as a
component of positive-negative selection. The system
can also function as a tool in somatic cell reprogramming
experiments to identify successfully reprogrammed plur-
ipotent cells. It can also be used to improve future human
somatic cell nuclear transfer protocols. With our ﬁrst
demonstration of its utility here and its many possible
applications, we envision that our ZUN system will
become a valuable selectivity tool for many facets of
stem cell research.
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